Prof. Heather Wakelee, Stanford University, USA
Host: Prof. Caicun Zhou, Department of Oncology, Shanghai East Hospital, China
Prof. Wakelee discussed the rapidly evolving landscape of ADCs and other antibody-based therapies in lung cancer, highlighting both the promise of these emerging treatments and the growing challenges they pose for patient selection and clinical decision-making.